Pebarin

Pebarin

pregabalin

Manufacturer:

Siam Bheasach

Distributor:

Siam Pharmaceutical

Marketer:

Siam Pharmaceutical
Concise Prescribing Info
Contents
Pregabalin
Indications/Uses
Central & peripheral neuropathic pain which includes diabetic peripheral neuropathy & post-herpetic neuralgia in adults. Generalized anxiety disorder in adults. Adjunctive therapy of partial seizures w/ or w/o secondary generalization in adults. Management of fibromyalgia.
Dosage/Direction for Use
Post-herpetic neuralgia 150-300 mg daily in 2 or 3 divided doses. Initially 75 mg bid or 50 mg tid & may be increased to 300 mg daily w/in 1 wk, or further increased to 600 mg in 2 or 3 divided doses in patients who do not experience adequate relief following 2-4 wk. Diabetic neuropathy Initially 150 mg daily in 3 divided doses, may be increased up to 300 mg daily in 3 divided doses w/in 1 wk. Generalized anxiety disorder 150-600 mg daily in 2 or 3 divided doses. Initially 150 mg daily in 2 or 3 divided doses, may be increased to 300 mg daily after 1 wk, then further increased to 450 mg daily following an additional wk. Max: 600 mg daily after an additional wk. Epilepsy 150-600 mg daily in 2 or 3 divided doses. Initially 75 mg bid or 50 mg tid, may be increased to max of 600 mg daily. Fibromyalgia 300-450 mg daily. Initially 75 mg bid, may be increased to 300 mg daily w/in 1 wk, then further increased to 225 mg bid in patients who do not experience adequate benefit. Renal impairment CrCl ≥60 mL/min Initially 150 mg daily, may be increased to 300 mg daily, then further increased to 450 mg daily up to max of 600 mg daily. All doses should be given in 2-3 divided doses; 30-60 mL/min Initially 75 mg daily, may be increased to 150 mg daily, then further increased to 225 mg daily up to max of 300 mg daily. All doses should be given in 2-3 divided doses; 15-30 mL/min Initially 25-50 mg daily, may be increased to 75 mg daily, then further increased to 100-150 mg daily up to max of 150 mg daily. All doses should be given in 1-2 divided doses; <15 mL/min Initially 25 mg daily, may be increased to 25-50 mg daily, then further increased to 50-75 mg daily up to max of 75 mg daily. All doses should be given once daily. Post-hemodialysis supplementary Patient on 25 mg once daily 25 or 50 mg, 25-50 mg once daily 50 or 75 mg, 50-75 mg once daily 75 or 100 mg, 75 mg once daily 100 or 150 mg. All doses should be given as single dose.
Administration
May be taken with or without food.
Contraindications
Special Precautions
Discontinue use if hypersensitivity occurs. Increased risk of suicidal thoughts or behavior. History of angioedema. Peripheral edema; CHF patients w/ NYHA class III or IV; unexplained muscle pain, tenderness or weakness; wt gain; blurred vision, decreased visual acuity, visual field changes; increased creatine kinase; decreased platelet count; prolonged PR interval. Monitor patients for emergence or worsening of depression, suicidal thoughts, or behavior &/or unusual mood or behavior changes. Avoid alcohol intake. Avoid abrupt discontinuation; taper-off gradually over at least 1 wk. Concomitant use w/ ACE inhibitors; thiazolidinedione antidiabetics. May affect ability to drive & use machines. Hepatic & renal disease. Pregnancy & lactation. Childn <18 yr. Elderly.
Adverse Reactions
Dizziness, somnolence, ataxia, abnormal thinking, tremor, confusion, twitching, myoclonus, amnesia, speech disorder, incoordination, abnormal gait, dry mouth, constipation, increased appetite, wt gain, peripheral edema, blurred & abnormal vision, diplopia, accidental injury, pain; headache, flatulence, vomiting, edema, facial edema, infection, flu syndrome; asthenia, neuropathy, vertigo, euphoria, hypoglycemia, back & chest pain, dyspnea; attention disturbance, balance disorder, memory impairment, hypoaesthesia, lethargy, anxiety, disorientation, depression, fatigue, abnormal feeling, fluid retention, feeling drunk, sinusitis, pharyngolaryngeal pain, arthralgia, muscle spasms.
Drug Interactions
Increased risk of developing angioedema w/ ACE inhibitors. Additive effect in cognitive & gross motor function impairment w/ CNS depressants eg, ethanol, lorazepam, oxycodone. Increased risk of edema, wt gain &/or fluid retention w/ thiazolidinedione antidiabetics.
MIMS Class
Anticonvulsants / Anxiolytics / Drugs for Neuropathic Pain
ATC Classification
N02BF02 - pregabalin ; Belongs to the class of gabapentinoids. Used to relieve pain and other conditions.
Presentation/Packing
Form
Pebarin cap 150 mg
Packing/Price
10's;7's
Form
Pebarin cap 25 mg
Packing/Price
7's
Form
Pebarin cap 75 mg
Packing/Price
10's;7's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in